292 related articles for article (PubMed ID: 6088584)
1. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
McEvoy RC; Andersson J; Sandler S; Hellerström C
J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
[TBL] [Abstract][Full Text] [Related]
2. B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice.
Feve B; Segain JP; Charbonnel B; Sai P
Diabetologia; 1990 Jan; 33(1):9-14. PubMed ID: 2137423
[TBL] [Abstract][Full Text] [Related]
3. Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response.
McEvoy RC; Thomas NM; Hellerström C; Ginsberg-Fellner F; Moran TM
Diabetologia; 1987 Apr; 30(4):232-8. PubMed ID: 2954873
[TBL] [Abstract][Full Text] [Related]
4. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.
Koevary SB
Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569
[TBL] [Abstract][Full Text] [Related]
5. Proteins spontaneously released by rat insulinoma (RIN) cells are anchored on cell membrane by a glycosyl-phosphatidyl-inositol link and inhibit increased RIN cell adhesion of lymphocytes from type 1 diabetic patients and non-obese diabetic mice in vitro.
Gouin E; Segain JP; Saï P
Diabetes Metab; 1996 Dec; 22(6):439-50. PubMed ID: 8985653
[TBL] [Abstract][Full Text] [Related]
6. Initial role of macrophage in the development of anti-beta-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice.
Ihm SH; Lee KU; Rhee BD; Min HK
Diabetes Res Clin Pract; 1990 Oct; 10(2):123-6. PubMed ID: 2175696
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune reactions in a patient with malignant insulinoma treated by multiple low dose streptozotocin.
Schulz B; Hehmke B; Zander E; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):77-82. PubMed ID: 2159401
[TBL] [Abstract][Full Text] [Related]
8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid cells of BB/W diabetic rats are cytotoxic to islet beta cells in vitro.
MacKay P; Boulton A; Rabinovitch A
Diabetes; 1985 Jul; 34(7):706-9. PubMed ID: 3891476
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.
MacKay P; Jacobson J; Rabinovitch A
J Clin Invest; 1986 Mar; 77(3):916-24. PubMed ID: 3512604
[TBL] [Abstract][Full Text] [Related]
11. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
Leiter EH; Beamer WG; Shultz LD
Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
[TBL] [Abstract][Full Text] [Related]
13. Low dose streptozotocin causes stimulation of the immune system and of anti-islet cytotoxicity in mice.
Kantwerk-Funke G; Burkart V; Kolb H
Clin Exp Immunol; 1991 Nov; 86(2):266-70. PubMed ID: 1657463
[TBL] [Abstract][Full Text] [Related]
14. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro.
Saï P; Pogu S; Ouary M
Diabetologia; 1991 Apr; 34(4):212-7. PubMed ID: 2065856
[TBL] [Abstract][Full Text] [Related]
15. Class II MHC antigen induction on rat insulinoma (RINm5F) and colon carcinoma (TS) cells by co-culture with diabetic and normal xenogenic lymphocytes.
Maugendre D; Godeau T; Feve B; Segain JP; Valentin A; Sai P; Houssaint E
J Autoimmun; 1989 Jun; 2(3):229-40. PubMed ID: 2765097
[TBL] [Abstract][Full Text] [Related]
16. Transfected rat islet tumour cells express mouse major histocompatibility complex class I antigens functionally. Applicable as "pseudo-syngeneic" targets in the multiple low-dose streptozotocin diabetes model.
Serup P; Schøller J
Diabetologia; 1989 Jul; 32(7):409-15. PubMed ID: 2553516
[TBL] [Abstract][Full Text] [Related]
17. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
Martignat L; Feve B; Charbonnel B; Sai P
Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
[TBL] [Abstract][Full Text] [Related]
18. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
[TBL] [Abstract][Full Text] [Related]
19. Studies on the chemical and immunological destruction of insulin-secreting islet cell tumours.
Flatt PR; Shibier O; Ioannides C; Swanston-Flatt SK
Exp Clin Endocrinol; 1989 May; 93(2-3):193-202. PubMed ID: 2550268
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
